In gastric cancer (GC) patient models, compared to healthy volunteers, the expression of TLR-2, TLR-3, TLR-4, and TLR-9 was significantly elevated in GC patients, with higher TLR expression observed in more advanced GC subtypes (124). This evidence concerns the gene TLR2 and gastric cancer.